Where does Nat Diagnostics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nat Diagnostics, Inc. ranks #48,970 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nat Diagnostics, Inc. hold?

Nat Diagnostics, Inc. holds 5 US utility patents granted between 2017 and 2025, spanning 2 technology areas.

What is Nat Diagnostics, Inc.'s Innovation Score?

Nat Diagnostics, Inc. has an Innovation Score of 39.5 out of 100 (top 38% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nat Diagnostics, Inc. focus on?

Nat Diagnostics, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 5 patents, ranking #2,660 of 7,863 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Is Nat Diagnostics, Inc.'s patent grant rate increasing or decreasing?

Nat Diagnostics, Inc.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Nat Diagnostics, Inc.'s patents?

Nat Diagnostics, Inc.'s patents average 25.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nat Diagnostics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nat Diagnostics, Inc.

USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nat ranks #48,970 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.

#48,970
of 49,997 US assignees by volume: Top 38%
by Innovation Score (39.5/100): 25.8
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R48970 · US Corporation #48,970 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,970/49,997
PHOTO-FINISH Nanotech Analysis S…
CPC-NARROW G01N · 2 areas
INNOV-THIN 39.5/100
CLAIMS-DENSE 25.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nanotech Analysis S.R.L. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nat’s 39.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (16%) Velocity 13.3 pts (34%) Breadth 5.0 pts (13%) Claim depth 15.0 pts (38%)

Qualcomm Incorporated · highest

85
Cloudminds (SHENZHEN… · near

40
Guided Therapy Systems · near

40
Image Analyser · near

40
LuxVue Technology · near

40
Nat Diagnostics · this assignee

40
3D Lighting… · lowest

7

What this shows Nat's Innovation Score is 39.5/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nat?

Each dot is one of Nat’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nat’s own 25.8 claims/patent is ABOVE the 13.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nat vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nat's grants concentrate

Nat Diagnostics, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). By volume, Nat sits between Nanotech Analysis S.R.L. and Natowatchbands.com, LLC.

Nat's three-year grant acceleration

Nat Diagnostics, Inc. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nanotech Analysis…

5
Nanoton

5
Nanotronics Health

5
Narwhal Medical

5
National Institut…

5
National Oilwell…

5
Nationstar Mortga…

5
Natowatchbands com

5
Nat Diagnostics ◀

5

What this shows Nat holds 5 patents at rank #49,117, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nat

By rank, the assignees closest to #49,117 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Nat's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nat, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Nat ranks #2,660 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Image Analyser Ltd. 40 Cloudminds (SHENZHEN) Robotics Systems Co., Ltd. 40 LuxVue Technology Corporation 40 Guided Therapy Systems, LLC 40

Nat's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 38% higher than 62% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Nat Diagnostics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	20.0%
2021	1	20.0%
2022	1	20.0%
2024	1	20.0%
2025partial year	1	20.0%

Which technologies does Nat Diagnostics, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nat Diagnostics, Inc.'s patent record in context - here's where to go next.

Nat Diagnostics, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 100% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #48,970 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nat Diagnostics, Inc. against Nanotech Analysis S.R.L., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.